

Microcap investor Jason Hirschman on his method, $XPEL and the Buffett salad oil scandal | S07 E29
10 snips Aug 28, 2025
Jason Hirschman, a microcap investor at Hudson 215 Capital, shares his unique approach to investing, likening it to the infamous salad oil scandal involving American Express. He discusses the complexities of microcap investing, highlighting both challenges and opportunities, especially in niche markets like Japan's evolving divorce law. With insights into undervalued stocks and the significance of market dynamics, Hirschman emphasizes the importance of fundamentals and operational efficiency, making for an engaging conversation on navigating the microcap landscape.
AI Snips
Chapters
Transcript
Episode notes
From Family Business To Buffett-Style Bets
- Jason traced his investing arc from five figures to nine figures and used Buffett's Amex example to teach salad-oil investing.
- He emphasizes buying when market fear is unrelated to the core franchise.
Buy When Non-Core Issues Distort Value
- "Salad oil" investing buys companies unfairly punished by non-core issues and captures combined value and growth.
- Jason used this idea with American Express and Expel to profit from core-business resilience.
Lab Test Led To Big Expel Bets
- Jason and a partner sent Expel samples to a lab and concluded the product didn't infringe 3M patents.
- That chemical report triggered him to buy aggressively, buying 40% of shares traded in a period.